3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
21
Other hematologic neoplasm
10
Plasma cell
4
Myeloid
4
Genitourinary
4
Dermatologic
2
Thoracic
1
Sarcoma
1
Other neoplasm
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Colorectal Neoplasms
3978
Pancreatic Neoplasms
2479
Carcinoma, Hepatocellular
2413
Stomach Neoplasms
2109
Rectal Neoplasms
1676
Colonic Neoplasms
1629
Esophageal Neoplasms
1312
Liver Neoplasms
878
Neoplasms
633
Breast Neoplasms
596
Cholangiocarcinoma
525
Gastrointestinal Neoplasms
468
Neoplasm Metastasis
456
Esophageal Squamous Cell Carcinoma
434
Lung Neoplasms
422
Biliary Tract Neoplasms
277
Prostatic Neoplasms
270
Ovarian Neoplasms
235
Barrett Esophagus
224
Adenocarcinoma Of Esophagus
202
Gallbladder Neoplasms
191
Head and Neck Neoplasms
185
Carcinoma, Non-Small-Cell Lung
185
Gastrointestinal Stromal Tumors
180
Anus Neoplasms
179
Recurrence
168
Melanoma
162
Adenocarcinoma
156
Uterine Cervical Neoplasms
153
Bile Duct Neoplasms
153
Interventions
palbociclib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Immune System Diseases
×
Gastrointestinal
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled